Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HRMY Harmony Biosciences Holdings, Inc.

Market Closed 03-13 16:00:00 EDT

27.61

-0.18

-0.65%

盘后27.18

-0.43-1.56%

18:01 EDT

High27.93	Low27.20	Vol478.79K
Open27.79	D1 Closing27.79	Amplitude2.63%
Mkt Cap1.59B	Tradable Cap1.23B	Total Shares57.60M
T/O13.18M	T/O Rate1.07%	Tradable Shares44.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HRMY","market":"US","secType":"STK","nameCN":"Harmony Biosciences Holdings, Inc.","latestPrice":27.61,"timestamp":1773432000000,"preClose":27.79,"halted":0,"volume":478788,"hourTrading":{"tag":"盘后","latestPrice":27.1784,"preClose":27.61,"latestTime":"18:01 EDT","volume":18855,"amount":520473.5212,"timestamp":1773439309096,"change":-0.4316,"changeRate":-0.015632,"amplitude":0.015632},"delay":0,"changeRate":-0.00647715005397624,"floatShares":44560063,"shares":57596358,"eps":2.71,"marketStatus":"Market Closed","change":-0.18,"latestTime":"03-13 16:00:00 EDT","open":27.79,"high":27.93,"low":27.2,"amount":13184751.907608,"amplitude":0.026268,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.71,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"adr":0,"listingDate":1597809600000,"exchange":"NASDAQ","adjPreClose":27.79,"preHourTrading":{"tag":"盘前","latestPrice":27.84,"preClose":27.79,"latestTime":"09:29 EDT","volume":40,"amount":1113.03008,"timestamp":1773408556071,"change":0.05,"changeRate":0.001799,"amplitude":0.025549},"postHourTrading":{"tag":"盘后","latestPrice":27.1784,"preClose":27.61,"latestTime":"18:01 EDT","volume":18855,"amount":520473.5212,"timestamp":1773439309096,"change":-0.4316,"changeRate":-0.015632,"amplitude":0.015632},"volumeRatio":0.7727412401845063,"impliedVol":0.6542,"impliedVolPercentile":0.6693},"requestUrl":"/m/hq/s/HRMY/tweets","defaultTab":"tweets","newsList":[{"id":"2617266598","title":"Harmony Biosciences Eyes Blockbuster Future After Record Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2617266598","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617266598?lang=en_us&edition=fundamental","pubTime":"2026-03-05 08:19","pubTimestamp":1772669975,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings, Inc. (($HRMY)) has held its Q4 earnings call. Read on for the main highlights of the call. Harmony Biosciences’ lates...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/harmony-biosciences-eyes-blockbuster-future-after-record-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/harmony-biosciences-eyes-blockbuster-future-after-record-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY","BK4007"],"gpt_icon":0},{"id":"2614118570","title":"Harmony Biosciences (HRMY) Is Down 20.1% After Reaffirming WAKIX Outlook and Winning Pediatric Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2614118570","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614118570?lang=en_us&edition=fundamental","pubTime":"2026-02-26 16:32","pubTimestamp":1772094724,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings recently reported Q4 2025 results showing net income of US$22.49 million and diluted EPS of US$0.38, alongside full-year 2025 net income of US$158.69 million and reiterated 2026 WAKIX net revenue guidance of US$1.00 billion to US$1.04 billion.\nAt the same time, FDA approval extending WAKIX to treat cataplexy in pediatric narcolepsy patients and progress securing its intellectual property framework could be important for Harmony’s long-term WAKIX franchise and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/harmony-biosciences-hrmy-is-down-201-after-reaffirming-wakix","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/harmony-biosciences-hrmy-is-down-201-after-reaffirming-wakix","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HRMY","BK4007"],"gpt_icon":0},{"id":"2614508717","title":"Oppenheimer Reaffirms Their Buy Rating on Harmony Biosciences Holdings (HRMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614508717","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614508717?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:16","pubTimestamp":1772025407,"startTime":"0","endTime":"0","summary":"In a report released today, Andreas Argyrides from Oppenheimer reiterated a Buy rating on Harmony Biosciences Holdings, with a price target of $62....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY","OPY"],"gpt_icon":0},{"id":"2614821740","title":"Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), CareDx (CDNA) and Sotera Health (SHC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614821740","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614821740?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:50","pubTimestamp":1772023845,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Harmony Biosciences Holdings (HRMY – Research Report), CareDx (CD...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-caredx-cdna-and-sotera-health-shc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-caredx-cdna-and-sotera-health-shc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY","BK4585","BK4121","LU0128526141.USD","LABU","BK4007","CDNA","XLV","XBI","BK4581","LU0029874061.USD","BK4023","BK4116","CD","HCSG","BK4588","SHC","BK4139","BK4137"],"gpt_icon":0},{"id":"2614081337","title":"Harmony Biosciences Holdings, Inc.  : Deutsche Bank Cuts Target Price to $30 From $31","url":"https://stock-news.laohu8.com/highlight/detail?id=2614081337","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614081337?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:07","pubTimestamp":1772021220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nAQN2LNOA1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"gpt_icon":0},{"id":"2614707616","title":"Harmony Biosciences Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2614707616","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614707616?lang=en_us&edition=fundamental","pubTime":"2026-02-25 17:39","pubTimestamp":1772012340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HRMY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 25, 2026 04:39 ET (09:39 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"gpt_icon":0},{"id":"1105253629","title":"Stock Track | Harmony Biosciences Soars 5.28% Intraday on Q4 Revenue Beat and Strong 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1105253629","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105253629?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:57","pubTimestamp":1771945063,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings, Inc. (HRMY) saw its stock price soar 5.28% during intraday trading on Tuesday. The significant upward movement followed the company's release of its fourth-quarter and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["HRMY"],"gpt_icon":0},{"id":"2613719481","title":"GUIDANCE: (HRMY) Harmony Biosciences Expects 2026 WAKIX Net Revenue Range $1.00B - $1.04B","url":"https://stock-news.laohu8.com/highlight/detail?id=2613719481","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613719481?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:43","pubTimestamp":1771936992,"startTime":"0","endTime":"0","summary":"GUIDANCE: (HRMY) Harmony Biosciences Expects 2026 WAKIX Net Revenue Range $1.00B - $1.04B","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HRMY"],"gpt_icon":0},{"id":"2613160027","title":"Harmony Biosciences Q4 Adj. EPS $0.57 Misses $0.90 Estimate, Sales $243.776M Beat $240.286M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2613160027","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613160027?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:31","pubTimestamp":1771936293,"startTime":"0","endTime":"0","summary":"Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.90 by 36.74 percent. This is a 48.18 percent decrease over earnings of $1.10 per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50810122/harmony-biosciences-q4-adj-eps-0-57-misses-0-90-estimate-sales-243-776m-beat-240-286m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"gpt_icon":0},{"id":"2613021716","title":"BRIEF-Harmony Biosciences Q4 Net Income USD 22.486 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2613021716","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613021716?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:30","pubTimestamp":1771936248,"startTime":"0","endTime":"0","summary":"Feb 24  - Harmony Biosciences Q4 gross profit USD 175.231 million.Q4 product revenue USD 243.776 million vs. IBES estimate USD 240.4 million. Q4 pretax profit USD 40.76 million vs. IBES estimate USD 66 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLX20144C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"gpt_icon":0},{"id":"2613871953","title":"Harmony Biosciences - Reiterated 2026 Wakix Net Revenue Guidance of $1.0 Bln - $1.04 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2613871953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613871953?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:30","pubTimestamp":1771936203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLX20144C:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"gpt_icon":0},{"id":"2613771951","title":"Harmony Biosciences Holdings Inc  Q4 Shr View $0.90 -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2613771951","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613771951?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:30","pubTimestamp":1771936203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLX20144C:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","HRMY"],"gpt_icon":0},{"id":"2613719510","title":"Harmony Biosciences - Qtrly Adj EPS $0.57","url":"https://stock-news.laohu8.com/highlight/detail?id=2613719510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613719510?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:30","pubTimestamp":1771936203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLX20144C:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"gpt_icon":0},{"id":"2613716065","title":"Harmony Biosciences Q4 Product Revenue USD 243.776 Million VS. Ibes Estimate USD 240.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2613716065","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613716065?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:30","pubTimestamp":1771936203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nPLX20144C:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"gpt_icon":0},{"id":"2613719807","title":"Press Release: Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2613719807","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613719807?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:30","pubTimestamp":1771936200,"startTime":"0","endTime":"0","summary":"WAKIX 2025 Net Revenue of $868.5 Million; 2026 WAKIX Net Revenue Guidance of $1.0 -- $1.04 Billion on Track for Blockbuster Status in Narcolepsy. Recently Completed Settlements with 3 Additional Generic Filers Toward Goal of Securing WAKIX Franchise. Pitolisant GR NDA Submission on Track for Q2 2026; Extends the Pitolisant Franchise into the 2040s. Exploring New Opportunities to Broaden the Pitolisant Franchise Beyond Orphan/Rare into Larger CNS Indications. Potential Best-In-Class Orexin-2 Agonist  Phase 1 Trial Ongoing; Clinical Data Expected in Mid-2026. Fourth Quarter and Full Year 2025 Net Product Revenue for WAKIX. --  Net product revenue for the quarter ended December 31, 2025, was $243.8. million, compared to $201.3 million for the same period in 2024. 8,500 patients in Q4 2025; representing the third consecutive quarter of. --  Net revenue projected between $1.0 billion to $1.04 billion for the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","PWS","HRMY","BK4232","BK4022","BK4007"],"gpt_icon":0},{"id":"2613379890","title":"U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2613379890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613379890?lang=en_us&edition=fundamental","pubTime":"2026-02-24 15:56","pubTimestamp":1771919787,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne TechnologiesFeb 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed comp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4N3ZK0LQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARES","DG","SMG","2NVD.UK","SMTC","MRVL","NTSK","EVER","WHD","VVX","OKTA","WGS","ZS","CRWL","WDAY","AVL","3NVD.UK","MAX","FRPT","BX","TPG","AVS","LH","CRWD","DPZ","EHAB","AVGW","APO","NVIW.SI","NVD2.UK","DIPS","SAIL","HRMY","AVGU","LIFE","AVGG","AVGX","BBBY","KEYS","CG","AVGO","KKR","OKTG","UCTT","GH","JLL","AXSM","NVDA","MNST","TDY"],"gpt_icon":1},{"id":"2613765918","title":"Is Harmony Biosciences (HRMY) Pricing Reflect Recent Share Slump And DCF Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2613765918","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613765918?lang=en_us&edition=fundamental","pubTime":"2026-02-24 11:25","pubTimestamp":1771903536,"startTime":"0","endTime":"0","summary":"If you are wondering whether Harmony Biosciences Holdings is attractively priced or misunderstood by the market, you are not alone. This article will walk through what the current share price really implies.\nThe stock last closed at US$26.87, after declines of 25.4% over the past week, 27.0% over the past month, and 21.4% over the past year. These moves may have changed how investors view both its potential and its risks.\nRecent news coverage around Harmony Biosciences has focused on the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/is-harmony-biosciences-hrmy-pricing-reflect-recent-share-slu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/is-harmony-biosciences-hrmy-pricing-reflect-recent-share-slu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","DCF","HRMY"],"gpt_icon":0},{"id":"2613818777","title":"Harmony Biosciences : Truist Securities Cuts to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2613818777","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613818777?lang=en_us&edition=fundamental","pubTime":"2026-02-23 20:02","pubTimestamp":1771848178,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nFWN3ZJ0SJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"gpt_icon":0},{"id":"2613789426","title":"Harmony Biosciences Holdings, Inc.  : Deutsche Bank Cuts to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2613789426","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613789426?lang=en_us&edition=fundamental","pubTime":"2026-02-23 19:57","pubTimestamp":1771847820,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nAQN2LNBBI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"gpt_icon":0},{"id":"2613183297","title":"Harmony Biosciences downgraded to Hold from Buy at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2613183297","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613183297?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:05","pubTimestamp":1771621534,"startTime":"0","endTime":"0","summary":"Truist analyst Danielle Brill downgraded Harmony Biosciences (HRMY) to Hold from Buy with no price target following the conclusion of its bench tri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-downgraded-to-hold-from-buy-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-downgraded-to-hold-from-buy-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","HRMY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.harmonybiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0254},{"period":"1month","weight":-0.2454},{"period":"3month","weight":-0.3184},{"period":"6month","weight":-0.1476},{"period":"1year","weight":-0.1562},{"period":"ytd","weight":-0.2622}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.035612},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.051691},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.019246},{"month":4,"riseRate":0,"avgChangeRate":-0.07831},{"month":5,"riseRate":0.6,"avgChangeRate":0.050645},{"month":6,"riseRate":0.6,"avgChangeRate":-0.007672},{"month":7,"riseRate":0.8,"avgChangeRate":0.041515},{"month":8,"riseRate":0.8,"avgChangeRate":0.05943},{"month":9,"riseRate":0.5,"avgChangeRate":-0.023406},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.006378},{"month":11,"riseRate":0.833333,"avgChangeRate":0.105341},{"month":12,"riseRate":0.5,"avgChangeRate":0.02881}],"exchange":"NASDAQ","name":"Harmony Biosciences Holdings, Inc.","nameEN":"Harmony Biosciences Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Harmony Biosciences Holdings, Inc.,HRMY,Harmony Biosciences Holdings, Inc.股票,Harmony Biosciences Holdings, Inc.股票老虎,Harmony Biosciences Holdings, Inc.股票老虎国际,Harmony Biosciences Holdings, Inc.行情,Harmony Biosciences Holdings, Inc.股票行情,Harmony Biosciences Holdings, Inc.股价,Harmony Biosciences Holdings, Inc.股市,Harmony Biosciences Holdings, Inc.股票价格,Harmony Biosciences Holdings, Inc.股票交易,Harmony Biosciences Holdings, Inc.股票购买,Harmony Biosciences Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}